1 Weber P, Bendich A & Schalch W (1996) Vitamin C and human health – a review of recent data relevant to human requirements. Int J Vitam Nutr Res 66, 19–30.
2 Institute of Medicine & National Academy of Sciences (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. . Washington, DC: National Academy Press.
3 Levine M, Conry-Cantilena C, Wang Y, et al. (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 93, 3704–3709.
4 Lykkesfeldt J, Loft S, Nielsen JB, et al. (1997) Ascorbic acid and dehydroascorbic acid as biomarkers of oxidative stress caused by smoking. Am J Clin Nutr 65, 959–963.
5 Frikke-Schmidt H & Lykkesfeldt J (2009) The role of marginal vitamin C deficiency in atherogenesis: in vivo models and clinical studies. Basic Clin Pharmacol Toxicol 104, 419–433.
6 Tveden-Nyborg P & Lykkesfeldt J (2009) Does vitamin C deficiency result in impaired brain development in infants? Redox Rep 14, 2–6.
7 Tveden-Nyborg P, Johansen LK, Raida Z, et al. (2009) Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. Am J Clin Nutr 90, 540–546.
8 Eichholzer M, Stahelin HB, Gey KF, et al. (1996) Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 66, 145–150.
9 Gale CR, Martyn CN, Winter PD, et al. (1995) Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 310, 1563–1566.
10 Khaw KT, Bingham S, Welch A, et al. (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 357, 657–663.
11 Loria CM, Klag MJ, Caulfield LE, et al. (2000) Vitamin C status and mortality in US adults. Am J Clin Nutr 72, 139–145.
12 Nyyssönen K, Parviainen MT, Salonen R, et al. (1997) Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 314, 634.
13 Riemersma RA, Wood DA, Macintyre CC, et al. (1991) Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337, 1–5.
14 Sahyoun NR, Jacques PF & Russell RM (1996) Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 144, 501–511.
15 Singh RB, Ghosh S, Niaz MA, et al. (1995) Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol 76, 1233–1238.
16 Blot WJ, Li JY, Taylor PR, et al. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85, 1483–1492.
17 Cook NR, Albert CM, Gaziano JM, et al. (2007) A randomized factorial trial of vitamins C and E and β carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 167, 1610–1618.
18 Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23–33.
19 Hercberg S, Galan P, Preziosi P, et al. (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164, 2335–2342.
20 Jacob RA (1990) Assessment of human vitamin C status. J Nutr 120, Suppl. 11, 1480–1485.
21 Smith JL & Hodges RE (1987) Serum levels of vitamin C in relation to dietary and supplemental intake of vitamin C in smokers and nonsmokers. Ann N Y Acad Sci 498, 144–152.
22 Lykkesfeldt J (2006) In Cigarette Smoke and Oxidative Stress, pp. 237–260 [Halliwell B and Poulsen HE, editors]. Berlin: Springer Verlag.
23 Kirk SF, Cade JE, Barrett JH, et al. (1999) Diet and lifestyle characteristics associated with dietary supplement use in women. Public Health Nutr 2, 69–73.
24 McNaughton SA, Mishra GD, Paul AA, et al. (2005) Supplement use is associated with health status and health-related behaviors in the 1946 British Birth Cohort. J Nutr 135, 1782–1789.
25 Sinha R, Frey CM, Kammerer WG, et al. (1994) Importance of supplemental vitamin C in determining serum ascorbic acid in controls from a cervical cancer case–control study: implications for epidemiological studies. Nutr Cancer 22, 207–217.
26 Lykkesfeldt J, Christen S, Wallock LM, et al. (2000) Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr 71, 530–536.
27 Carr AC & Frei B (1999) Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 69, 1086–1107.
28 Levine M, Dhariwal KR, Welch RW, et al. (1995) Determination of optimal vitamin C requirements in humans. Am J Clin Nutr 62, Suppl. 6, 1347S–1356S.
29 Levine M, Rumsey S & Wang Y (1997) Principles involved in formulating recommendations for vitamin C intake: a paradigm for water-soluble vitamins. Meth Enzymol 279, 43–54.
30 Levine M, Padayatty SJ, Katz A, et al. (2004) . In Vitamin C: Its Functions and Biochemistry in Animals and Plants, pp. 291–317 [Asard H, May JM and Smirnoff N, editors]. Oxford: BIOS Scientific Publishers Ltd.
31 Newton HM, Schorah CJ, Habibzadeh N, et al. (1985) The cause and correction of low blood vitamin C concentrations in the elderly. Am J Clin Nutr 42, 656–659.
32 Schorah CJ, Newill A, Scott DL, et al. (1979) Clinical effects of vitamin C in elderly inpatients with low blood-vitamin-C levels. Lancet i, 403–405.
33 Chazan JA & Mistilis SP (1963) The pathophysiology of scurvy. A report of seven cases. Am J Med 34, 350–358.
34 Lind J (1753) A Treatise on the Scurvy. In Three Parts. Containing an Enquiry Into The Nature, Causes and Cure of That Disease, Together With a Critical and Chronological View of What Has Been Published on the Subject. Edinburgh: Sands, Murray, and Cochran.
35 Leggott PJ, Robertson PB, Rothman DL, et al. (1986) The effect of controlled ascorbic acid depletion and supplementation on periodontal health. J Periodontol 57, 480–485.
36 Langlois M, Duprez D, Delanghe J, et al. (2001) Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 103, 1863–1868.
37 Mayland CR, Bennett MI & Allan K (2005) Vitamin C deficiency in cancer patients. Palliat Med 19, 17–20.
38 Schectman G (1993) Estimating ascorbic acid requirements for cigarette smokers. Ann N Y Acad Sci 686, 335–345.
39 Hodges RE, Hood J, Canham JE, et al. (1971) Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr 24, 432–443.
40 Reuler JB, Broudy VC & Cooney TG (1985) Adult scurvy. JAMA 253, 805–807.
41 Simon JA, Hudes ES & Tice JA (2001) Relation of serum ascorbic acid to mortality among US adults. J Am Coll Nutr 20, 255–263.
42 Yokoyama T, Date C, Kokubo Y, et al. (2000) Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community: The Shibata Study. Stroke 31, 2287–2294.
43 Gey KF, Stahelin HB, Puska P, et al. (1987) Relationship of plasma level of vitamin C to mortality from ischemic heart disease. Ann N Y Acad Sci 498, 110–123.
44 Gey KF, Moser UK, Jordan P, et al. (1993) Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 57, 787S–797S.
45 Gey KF, Stahelin HB & Eichholzer M (1993) Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 71, 3–6.
46 Azzi A (2007) Molecular mechanism of α-tocopherol action. Free Radic Biol Med 43, 16–21.
47 Poulsen HE, Andersen JT, Keiding N, et al. (2009) Why epidemiological and clinical intervention studies often give different or diverging results? IUBMB Life 61, 391–393.
48 Bjelakovic G, Nikolova D, Gluud LL, et al. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842–857.
49 Kjaergard LL, Villumsen J & Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135, 982–989.
50 Hampl JS, Taylor CA & Johnston CS (2004) Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 94, 870–875.
51 Schectman G, Byrd JC & Gruchow HW (1989) The influence of smoking on vitamin C status in adults. Am J Public Health 79, 158–162.
52 Simon JA, Murtaugh MA, Gross MD, et al. (2004) Relation of ascorbic acid to coronary artery calcium: The Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 159, 581–588.
53 Wrieden WL, Hannah MK, Bolton-Smith C, et al. (2000) Plasma vitamin C and food choice in the third Glasgow MONICA population survey. J Epidemiol Community Health 54, 355–360.
54 Hercberg S, Preziosi P, Galan P, et al. (1994) Vitamin status of a healthy French population: dietary intakes and biochemical markers. Int J Vitam Nutr Res 64, 220–232.
55 McKeown-Eyssen G, Holloway C, Jazmaji V, et al. (1988) A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 48, 4701–4705.
56 Penn ND, Purkins L, Kelleher J, et al. (1991) The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 20, 169–174.
57 Chandra RK (1992) Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 340, 1124–1127.
58 Wenzel G, Kuklinski B, Ruhlmann C, et al. (1993) Alcohol-induced toxic hepatitis – a ‘free radical’ associated disease. Lowering fatality by adjuvant antioxidant therapy (article in German). Z Gesamte Inn Med 48, 490–496.
59 ter Riet G, Kessels AG & Knipschild PG (1995) Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers. J Clin Epidemiol 48, 1453–1460.
60 Hogarth MB, Marshall P, Lovat LB, et al. (1996) Nutritional supplementation in elderly medical in-patients: a double-blind placebo-controlled trial. Age Ageing 25, 453–457.
61 Girodon F, Lombard M, Galan P, et al. (1997) Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 41, 98–107.
62 You WC, Chang YS, Heinrich J, et al. (2001) An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur J Cancer Prev 10, 257–263.
63 Sasazuki S, Sasaki S, Tsubono Y, et al. (2003) The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection. Cancer Sci 94, 378–382.
64 Bonelli L, Camoriano A, Ravelli P, et al. (1998) . In Proceedings of International Selenium Tellurium Development Association, pp. 91–94 [Palmieri Y, editor]. Scottsdale, AZ: Selenium Tellurium Development Association.
65 Li JY, Taylor PR, Li B, et al. (1993) Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85, 1492–1498.
66 Greenberg ER, Baron JA, Tosteson TD, et al. (1994) A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 331, 141–147.
67 Pike J & Chandra RK (1995) Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vitam Nutr Res 65, 117–121.
68 Richer S (1996) Multicenter ophthalmic and nutritional age-related macular degeneration study – part 2: antioxidant intervention and conclusions. J Am Optom Assoc 67, 30–49.
69 Girodon F, Galan P, Monget AL, et al. (1999) Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 159, 748–754.
70 Correa P, Fontham ET, Bravo JC, et al. (2000) Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 92, 1881–1888.
71 Jacobson JS, Begg MD, Wang LW, et al. (2000) Effects of a 6-month vitamin intervention on DNA damage in heavy smokers. Cancer Epidemiol Biomarkers Prev 9, 1303–1311.
72 Age Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and β carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119, 1439–1452.
73 Brown BG, Zhao XQ, Chait A, et al. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345, 1583–1592.
74 Chylack LT Jr, Brown NP, Bron A, et al. (2002) The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 9, 49–80.
75 Graat JM, Schouten EG & Kok FJ (2002) Effect of daily vitamin E and multivitamin–mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 288, 715–721.
76 Waters DD, Alderman EL, Hsia J, et al. (2002) Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288, 2432–2440.
77 White KL, Chalmers DM, Martin IG, et al. (2002) Dietary antioxidants and DNA damage in patients on long-term acid-suppression therapy: a randomized controlled study. Br J Nutr 88, 265–271.
78 Prince MI, Mitchison HC, Ashley D, et al. (2003) Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther 17, 137–143.
79 Salonen RM, Nyyssonen K, Kaikkonen J, et al. (2003) Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107, 947–953.
80 Allsup SJ, Shenkin A, Gosney MA, et al. (2004) Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J Am Geriatr Soc 52, 20–24.
81 Richer S, Stiles W, Statkute L, et al. (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75, 216–230.
82 Avenell A, Campbell MK, Cook JA, et al. (2005) Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. BMJ 331, 324–329.
83 Mooney LA, Madsen AM, Tang D, et al. (2005) Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol Biomarkers Prev 14, 237–242.
84 Tam LS, Li EK, Leung VY, et al. (2005) Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol 32, 275–282.
85 Witte KK, Nikitin NP, Parker AC, et al. (2005) The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 26, 2238–2244.